Evidence map›Paper›PMID 27553241›Full record

ArticleAdvances in experimental medicine and biology2016

Serial Femtosecond Crystallography of Membrane Proteins.

Lan Zhu, Uwe Weierstall, Vadim Cherezov, Wei Liu

Abstract read
In one paragraph

Article in Advances in experimental medicine and biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Selection of Biophysical Methods for Characterisation of Membrane Proteins.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lan ZhuSchool of Molecular Sciences, Arizona State University, Tempe, AZ, 85287, USA.
Uwe WeierstallCenter for Applied Structural Discovery at the Biodesign Institute, Arizona State University, Tempe, AZ, 85287-1604, USA.
Vadim CherezovBridge Institute, University of Southern California, Los Angeles, CA, 90089, USA.
Wei LiuSchool of Molecular Sciences, Arizona State University, Tempe, AZ, 85287, USA. w.liu@asu.edu.

Funding

Project 3U54GM094618 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI STEVENS, RAYMOND C · 2010 to 2014
$17.1M
HT structure determination of GPCRs by LCP serial femtosecond nanocrystallographyR01GM108635 · NIGMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CHEREZOV, VADIM · 2014 to 2017
$1.5M
NIGMS NIH HHS R01 GM108635NIGMS NIH HHS U54 GM094618
6 · The paper itself

Abstract

Membrane proteins, including G protein-coupled receptors (GPCRs), constitute the most important drug targets. The increasing number of targets requires new structural information, which has proven tremendously challenging due to the difficulties in growing diffraction-quality crystals. Recent developments of serial femtosecond crystallography at X-ray free electron lasers combined with the use of membrane-mimetic gel-like matrix of lipidic cubic phase (LCP-SFX) for crystal growth and delivery hold significant promise to accelerate structural studies of membrane proteins. This chapter describes the development and current status of the LCP-SFX technology and elaborates its future role in structural biology of membrane proteins.

Indexed as

Bacterial ProteinsCrystallizationCrystallography, X-RayElectronsHumansLasersLipid BilayersMembrane ProteinsReceptors, G-Protein-CoupledSynchrotronsTemperatureTime FactorsBacterial ProteinsLipid BilayersMembrane ProteinsReceptors, G-Protein-CoupledG protein-coupled receptorsLCP injectorLCP-SFXLipidic cubic phaseMembrane proteinsSerial femtosecond crystallographyX-ray free electron laser

Identifiers

PMID27553241
PMCPMC5110035

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.